Ophthalmology
Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction
Hovione
PR-M03-21-003Mar 17, 2021
Proof-of-Concept Trial
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
PR-M11-20-014Nov 18, 2020
Study Results
Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress
Theravance Biopharma, Inc.
PR-M03-19-NI-078Mar 27, 2019
Oncology
ImaginAb Enrolls First Patient in Phase II Clinical Trial
ImaginAb
PR-M01-19-NI-066Jan 23, 2019
Study Results
Eisai And Biogen Present Detailed Results From Phase II Clinical Study Of Elenbecestat In MCI And Mild To Moderate Alzheimer's Disease
Eisai
PR-M07-18-NI-103Jul 31, 2018